Additional Xiaflex® Treatment in Patients With Peyronie's Disease

Updated 04/19/2024

Status Recruiting

Clinical Trial Summary

Subjects who have had an incomplete response to previous Xiaflex® will receive up to 4 additional cycles of treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03767452
Study type	Interventional
Source	Manhattan Medical Research Practice, PLLC
Contact	Harper Scott
Phone	212-480-3333
Email	info@manhattanmedicalresearch.com
Status	Recruiting
Phase	Phase 4
Start date	October 4, 2018
Completion date	February 2020

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01685437` - A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease	Phase 3
	Completed	`NCT01430169` - Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease	Phase 2
	Completed	`NCT01221597` - Study of AA4500 in the Treatment of Peyronie's Disease	Phase 3
	Recruiting	`NCT05108558` - Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders	Phase 4
	Recruiting	`NCT05147779` - Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis	Phase 1
	Completed	`NCT02267460` - An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease	Phase 3
	Completed	`NCT01221623` - Study of AA4500 in the Treatment of Peyronie's Disease	Phase 3
	Completed	`NCT02298829` - Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease
	Completed	`NCT01243411` - A Study of AA4500 in Men With Peyronie's Disease	Phase 3
	Completed	`NCT01578473` - Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease	Phase 1
	Not yet recruiting	`NCT05855070` - Intralesional Hyaluronic Acid and Verapamil Injection in Peyronie's Disease	N/A
	Completed	`NCT02072018` - Peyronie's Disease Treatment Protocol	Phase 1
	Terminated	`NCT05873595` - Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease
	Active, not recruiting	`NCT04786106` - Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's	Phase 4
	Completed	`NCT00812838` - H-22411: BOTOX® for Peyronie's Disease	Phase 2
	Completed	`NCT02395029` - Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD	Phase 1
	Completed	`NCT00755222` - The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease	Phase 2